2019 Confirmed Speakers:

Prasad S. Adusumilli, MD, Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center (CTC), Memorial Sloan-Kettering Cancer Center

Jeff Ahlgren, PhD, Senior Application Scientist, Wyatt Technology

Evren Alici, MD, PhD, Assistant Professor of Hematology, Karolinska Institutet, Department of Medicine, Stockholm, Sweden

Julian Andreev, PhD, Senior Staff Scientist, Oncology and Angiogenesis, Regeneron Pharmaceuticals

Michael Anyadiegwu, PhD, Senior Scientist, Downstream Processing, Centre for Process Innovation Ltd., National Biologics Manufacturing Centre

Tia Arena, MSc, Engineer I, Department of Cell Culture, Genentech

Paul Armistead, MD, PhD, Associate Professor, Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

Tara Arvedson, PhD, Director, Oncology Research, Amgen, Inc.

George Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG

Sven Bahrke, PhD, Senior Director, Research & Development, Glycotope GmbH

Chris Bailey-Kellogg, PhD, Professor, Computer Science, Dartmouth College

Bryan Balthazor, MA, Scientist, Pharmaceutical Research and Development, Pfizer, Inc.

Ashok D. Bandaranayake, PhD, Director, Bioprocess Development and Automation, Protein Therapeutics Program, Fred Hutchinson Cancer Research Center

Alex Bankovich, PhD, Senior Director, Late Stage Research, Abbvie Stemcentrx, LLC

Jessica Banks, PhD, Scientist, Drug Product Analytical Development, Moderna Therapeutics 

Anton Bauer, PhD, MBA, COO, R&D, The Antibody Lab GmbH

Matthew Bernett, PhD, Associate Director, Protein Engineering, Xencor, Inc.

Kyle Biggar, PhD, Assistant Professor & Director, Carleton Functional Proteomics Facility, Biochemistry, Carleton University

Basar Bilgicer, PhD, Associate Professor, Chemical and Biomolecular Engineering, Mike and Josie Harper Cancer Research Institute, NDnano Center for Nano Science and Technology, University of Notre Dame

Philippe Billiald, PharmD, PhD, Professor, Biochemistry, University of Paris-Sud; Co-Founder, Acticor Biotech

Uli Binder, MSc, CTO, XL-protein GmbH

Joerg Birkenfeld, PhD, Section Head, High Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis Deutschland GmbH

John W. Blankenship, PhD, Senior Investigator, Antibody Discovery, Novartis Institutes for BioMedical Research, Inc.

Ruben Boado, PhD, Vice President, Research & Development/Co-Founder, ArmaGen, Inc.

Robin Bogner, PhD, Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut

Jeffrey Boyles, MSc, Research Scientist, Biotechnology Discovery Research, Eli Lilly and Company

Andrew M. Bradbury, PhD, MB BS, CSO, Specifica, Inc.

David Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC

Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute

Nathan Brown, PhD, Senior Scientist III, Global Biologics, AbbVie, Inc.

Bradley C. Bundy, PhD, Associate Professor, Department of Chemical Engineering, Brigham Young University

Johannes Buyel, Dr. rer. nat., Dr.-Ing., MSc, Head, Integrated Production Platforms, Fraunhofer Institute for Molecular Biology and Applied Ecology IME

William Callahan, MSc, Senior Scientist, Process Development, Amgen

Mauro Castellarin, PhD, Postdoctoral Researcher, Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine

Balu Chakravarthy, PhD, Senior Research Officer, Human Health Therapeutics, National Research Council

Javier Chaparro-Riggers, PhD, Senior Director, Protein Engineering, Pfizer

Chao-Guang Chen, PhD, Senior Scientist, Research Department, CSL Limited

Qingfeng Chen, PhD, Principal Investigator, Institute of Molecular and Cell Biology, A*STAR, Singapore

Wen-Hsiang Chen, PhD, Assistant Professor, Department of Pediatric, Section of Tropical Medicine, Baylor College of Medicine

Yvonne Chen, PhD, Assistant Professor, Chemical & Biomolecular Engineering, UCLA

Yuan Cheng, PhD, Principal Scientist, Medicinal Chemistry, Amgen, Inc.

Yuan Cheng, PhD, Senior Research Investigator, Discovery Pharmaceutics & Analytical Sciences Bristol-Myers Squibb

Gabriel W.C. Cheung, PhD, Senior Director, BioMedicine Design, Medicinal Sciences, Worldwide Research and Development, Pfizer, Inc.

Henry C. Chiou, PhD, Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific

Choi-Fong Cho, PhD, Instructor, Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School

Marcus T. Cicerone, PhD, Project Leader, Biomaterials Group, National Institute of Standards and Technology

Jannick Cizeau, PhD, Director, Research, Sesen Bio, Inc.

Patricia L. Clark, PhD, O’Hara Professor of Chemistry & Biochemistry; Concurrent Professor of Chemical & Biomolecular Engineering, University of Notre Dame

Howard R.G. Clarke, PhD, Principal Scientist, Cell Sciences, Seattle Genetics 

Matthew Coleman, PhD, Senior Scientist, Physical Life Sciences, Lawrence Livermore National Laboratory (LLNL)

Christopher Corbeil, PhD, Research Officer, Human Health Therapeutics, National Research Council Canada

Carly Cox, Process Informatics Manager, Global Engineering, Pfizer

Manon Cox, PhD, Co-Founder & CEO, NextWaveBio

Steven Cramer, PhD, William Weightman Walker Professor, Isermann Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute

Marc Damelin, PhD, Senior Director, Biology, Mersana Therapeutics, Inc.

Trevor Deeks, PhD, QA/QC and GMP Consultant, Deeks Pharmaceutical Consulting Services, LLC

Jan-Willem de Gier, PhD, Associate Professor, Department of Biochemistry and Biophysics, Stockholm University

Brandon DeKosky, PhD, Assistant Professor, Pharmaceutical Chemistry and Chemical Engineering, University of Kansas

Matthew P. DeLisa, PhD, William L. Lewis Professor, Chemical & Biomolecular Engineering, Cornell University

Roberto DePaz, PhD, Associate Director, Formulation & Drug Product Development, RegenxBio

Antu K. Dey, MSc, PhD, Senior Director, R&D, Vaccine Product Development Center, International AIDS Vaccine Initiative (IAVI)

Himanshu Dhamankar, PhD, Senior Scientist, Pathway & Process Development, GreenLight Biosciences Inc.

Kumar Dhanasekharan, PhD, Senior Director and Head, Biologics Process and Analytical Development, Amicus Therapeutics

Iskandar Dib, PhD, Principal Scientist, Process Development & Analytics, VTU Technology GmbH

Dimiter Dimitrov, PhD, Director, Center for Antibody Therapeutics, University of Pittsburgh Medical School

Mario Dipaola, PhD, Senior Scientific Director, Biologics, Charles River Laboratory

Rakesh Dixit, PhD, Vice President and Global Head, Translational Sciences-Biologics Safety Assessment, MedImmune, LLC

Nidhi Doshi, MSc, Senior Research Associate, Late Stage Pharmaceutical Development, Genentech

John Dresios, PhD, Senior Biology Director, Chief Scientist and Leidos Technical Fellow, Advanced Solutions Group, Leidos

Zhimei Du, PhD, Director, Bioprocess & Clinical Manufacturing, Merck

Jennifer Dumont, PhD, Executive Director, Medical Affairs, Bioverativ, Inc.

Roland L. Dunbrack, Jr., PhD, Professor, Institute for Cancer Research, Fox Chase Cancer Center

Diego Ellerman, PhD, Principal Scientific Researcher, Protein Chemistry, Genentech, Inc.

Sam Ellis, Vice President, Biochemist, Thomson Instrument Company

Peter Ellmark, PhD, Vice President, Discovery, Alligator Bioscience AB, Sweden

Ulla Elofsson, PhD, Associate Professor, Senior Scientist, RISE Research Institutes of Sweden

Daniel Emerling, PhD, Senior Vice President, Research, Atreca, Inc.

James Ernst, PhD, Senior Scientist, Protein Chemistry, Genentech, Inc.

Ulrich Ernst, PhD, COO and Senior Vice President, Technical Operations at Amunix

Elizabeth Evans, PhD, Vice President, Preclinical Research, Vaccinex, Inc. 

Michael Evans, PhD, Assistant Professor, Radiology and Biomedical Imaging, University of California, San Francisco

Raphael Fish, Engineer I, Process Development, Genentech

Lauren Fontana, PhD Candidate, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut

Luca Fornelli, PhD, Assistant Professor, Biology, University of Oklahoma

Johan Fransson, PhD, Director, Antibody Discovery and Development, Northern Biologics

Jeremy Fry, Director, Sales, ProImmune Ltd.

Peter Fung, Senior Manager, Product Marketing, NanoTemper Technologies Inc.

Anna Millqvist Fureby, PhD, Centre Director, NextBioForm; Senior Scientist, Surface, Process and Formulation, RISE Research Institutes of Sweden 

Norbert Furtmann, PhD, Lab Head, Bioinformatics, High Throughput Biologics, Sanofi-Aventis Deutschland GmbH

Christian Gieffers, PhD, Vice President, Analytics/Protein Chemistry, Apogenix AG

Mark C. Glassy, PhD, Chief Science Officer, Nascent Biotech

Ulrich Goepfert, PhD, Principal Scientist, Large Molecule Research, Roche Pharma Research & Early Development, Roche Innovation Center Munich

Shalom Goldberg, PhD, Principal Scientist, Discovery Sciences, Janssen Research & Development/Johnson & Johnson

Christopher H. Gray, PhD, Staff Scientist & Team Leader (Structural Biology), Drug Discovery Program, CRUK Beatson Institute

Matthew Greving, PhD, Co-Founder, Vice President, Technology, RubrYc Therapeutics 

Zhenyu Gu, PhD, Development Scientist, Global Analytical and Pharmaceutical Development, Alexion Pharmaceuticals

Andras Guttman, PhD, DSc, Professor, Horvath Csaba Laboratory for Bioseparation Sciences

Markus Haberger, PhD, Senior Scientist, Pharma Technical Development Analytics Extended Characterization, Roche Diagnostics GmbH

Denise Karaoglu Hanzatian, PhD, Principal Research Scientist, Biologics Discovery, AbbVie

Christian Harding, PhD, CSO, VaxNewMo

Philip E. Hass, Senior Scientific Manager, Genentech, Inc.

Andrea Hawe, PhD, CSO, Coriolis Pharma Research GmbH

Dongping He, MS, Senior Scientific Researcher, Biochemical & Cellular Pharmacology, Genentech/Roche 

Philip M. Hemken PhD, Principal Scientist, R&D, Abbott Laboratories

Jennifer Hill, PhD, Team Lead, MS & NMR Analytics, National Research Council Canada (NRC)

Mitchell Ho, PhD, Senior Investigator, National Cancer Institute, NIH

Isidro Hotzel, PhD, Senior Scientist, Genentech

Philip Howard, PhD, Senior Fellow, MedImmune, Inc.; CSO, Spirogen, Ltd.

Alan K. Hunter, PhD, Director, Purification Process Sciences, MedImmune, LLC

John Huynh, PhD, Senior Director, Manufacturing Science & Technology, Gene Therapy Program, University of Pennsylvania

Paul Imbach, MD, Professor, Ped. Oncology/Hematology, University of Basel, Switzerland

Peter M. Ihnat, PhD, Principal Scientist, Biologics Preformulation and Drug Delivery, Abbvie Bioresearch Center

Gregory C. Ippolito, PhD, Research Assistant Professor, Molecular Biosciences, Georgiou Lab, The University of Texas at Austin

Miroslaw Janowski, MD, PhD, Associate Professor, Radiology, Johns Hopkins University

Roy Jefferis, PhD, MRCP, FRC Path, DSc, Emeritus Professor, Institute of Immunology & Immunotherapy, University of Birmingham

Jan Jezek, PhD, CSO, Research & Development, Arecor, Ltd.

Xin Jiang, Product Manager, iCE Marketing, ProteinSimple

Keith A. Johnson, PhD, Senior Principal Scientist, Analytical Research and Development, Pfizer

Matt Johnson, PhD, CTO, Avacta Life Sciences 

Stephen Johnston, PhD, CEO, Calviri, Inc., Director and Professor, Biodesign Center for Innovations in Medicine, Arizona State University

Aled Jones, PhD, Senior Product & Applications Manager, Marketing, ProZyme

Paul Jorjorian, Vice President, BioProcess Sciences, Thermo Fisher Scientific

Simpson Joseph, PhD, Professor, Department of Chemistry & Biochemistry, University of California, San Diego

Pranav Joshi, M. Tech, PhD Candidate, Bioengineering, McGill University

Alexander (Sasha) Kabanov, PhD, DrSci, Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina and Chapel Hill

Cavan Kalonia, PhD, Scientist, Late Stage Formulation Sciences, MedImmune

Masamichi Kamihira, PhD, Professor, Faculty of Engineering, Department of Chemical Engineering, Kyushu University

Jichao (Jay) Kang, PhD, RAC, Director, Analytical Development, Amicus

Bo Kara, Head, Process Development, Cell & Gene Therapy Platform CMC, GSK

Christos Karamitros, PhD, Director, Protein Engineering, Aeglea Biotherapeutics

John Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.

Donald E. Kerkow, PhD, Director, Biopharmaceutical Development, KBI Biopharma Inc.

Woojoo Eunice Kim, PhD Candidate, Burkart Lab, Department of Chemistry and Biochemistry, University of California, San Diego

Marina Kirkitadze, PhD, Deputy Director, Head of Biophysics and Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur, Canada

Kei Kishimoto, PhD, CSO, Selecta Biosciences

Georg Klima, Dipl. Ing., Executive Director, Process Science, Boehringer Ingelheim RCV GmbH & Co. KG

Harald Kolmar, PhD, Professor, Applied Biochemistry, Technical University Darmstadt

Yelena Kovtun, PhD, Associate Director, Pipeline Research and Development, ImmunoGen, Inc.

Edward Kraft, PhD, Senior Scientific Manager, BioMolecular Resources, Genentech, Inc.

Susan Krueger, PhD, NIST Center for Neutron Research, National Institute of Standards and Technology

Brian Kuhlman, PhD, Professor, Biochemistry and Biophysics, University of North Carolina at Chapel Hill

Joshua R. Laber, PhD, Postdoctoral Fellow, AbbVie Bioresearch Center, Preformulations/Drug Product Development, AbbVie

Steven LaBrenz, PhD, Scientific Director, Cell and Developability Sciences, Janssen R&D, BioTherapeutic Development

Runy Adeline Lam, PhD, Researcher, Chugai Pharmabody Research, Japan

Thomas Laue, PhD, Professor Emeritus, Molecular, Cellular and Biomedical Sciences, University of New Hampshire

TS Andrew LeBeau, PhD Senior Manager, Biologics, Marketing, Dotmatics Inc.

Jonas Lee, PhD, Scientist, Amgen

Howard Levine, PhD, President and CEO, BioProcess Technology Consultants

Nathan E. Lewis, PhD, Assistant Professor, Department of Pediatrics, University of California, San Diego

Brian Lobo, PhD, Associate Director, Formulation Development, MedImmune

Kelly Loyet, PhD, Senior Scientist, Biochemical and Cellular Pharmacology, Genentech

Jacek Lubelski, PhD, Vice President, Global Pharmaceutical Development, uniQure

Lin M. Luis, Senior Research Associate, Late Stage Pharmaceutical Development, Genentech

Sheila G. Magil, PhD, Senior Consultant, BioProcess Technology Consultants, Inc.

James D. Marks, MD, PhD, Chief of Staff, Chief of Performance Excellence, Zuckerberg San Francisco General Hospital and Trauma Center; Professor of Anesthesia, UCSF Department of Anesthesia and Perioperative Care

Sandro Matosevic, PhD, Assistant Professor, Department of Industrial and Physical Pharmacy, Purdue University

Jennifer Maynard, PhD, Associate Professor, Chemical Engineering, University of Texas at Austin

Yariv Mazor, PhD, Senior Scientist, Antibody Discovery & Protein Engineering
MedImmune LLC

Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia

Kimberly McDowell, PhD, Research Scientist, Preclinical Research, Proclara Biosciences, Inc.

Gary McLean, PhD, Reader in Molecular Immunology, Cellular and Molecular Immunology Research Centre, London Metropolitan University; Honorary Senior Research Fellow, National Heart and Lung Institute, Imperial College London

Shrenik Mehta, Postdoctoral Fellow, Genentech

Sebastian Meyer, PhD, COO, Numab Innovation AG

Enkelejda Miho, PhD, Professor, Digital Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland, Switzerland 

Stephen D. Miller, PhD, Judy Gugenheim Research Professor, Director, Interdepartmental Immunobiology Center, Microbiology-Immunology, Northwestern University Medical School

Brittney J. Mills, PhD, Senior Scientist II, Drug Product Development, AbbVie, Inc.

Marissa Mock, PhD, Principal Scientist, Therapeutic Discovery, Amgen

Paul Moore, PhD, Vice President, Immunology & Cell Biology, MacroGenics, Inc.

Alessandro Mora, PhD, Senior Scientist, CMC, Jounce Therapeutics

Sherie Morrison, PhD, Distinguished Research Professor, Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles

Ehab Moussa, PhD, Senior Scientist, Drug Product Development, AbbVie, Inc.

Monica Moya, PhD, Research Engineer, Materials Engineering Division, Lawrence Livermore National Laboratory

Vel Murugan, PhD, MBA, Research Scientist, Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University

Vladimir Muzykantov, MD, PhD, Professor, Pharmacology, The Center for Translational Targeted Therapeutics and Nanomedicine (CT3N) and Systems Pharmacology, Perelman School of Medicine, University of Pennsylvania

Rajiv Nayar, PhD, President, HTD Biosystems, Inc.

Reza Nejadnik, PhD, Laboratory Head Formulation Development Biologics, Global Pharmaceutical Development Biologics, Sanofi

Kelcy Newell, PhD, Senior Scientist, Laboratory Automation & High-Throughput Process Development, MedImmune, LLC

Feng Ni, PhD, Project Lead and Laboratory Supervisor, Human Health Therapeutics, National Research Council Canada

Henrike Niederholtmeyer, PhD, Postdoctoral Fellow, Devaraj Lab, Department of Chemistry and Biochemistry, University of California San Diego

R. Paul Nobrega, PhD, Scientist, Protein Analytics, Adimab, LLC

Vincent Noireaux, PhD, Associate Professor, Synthetic Biology, Biological Physics, University of Minnesota

Satoshi Ohtake, PhD, Senior Director, Pharmaceutical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer, Inc.

Marco Oldiges, PhD, Professor and Head, Bioprocesses and Bioanalytics, Institute of Bio- and Geosciences, IBG-1, Biotechnology, Forschungszentrum Jülich GmbH

Takeshi Omasa, PhD, Professor, Department of Material and Life Science, Graduate School of Engineering, Osaka University

Raquel Orozco, PhD, Senior Bioprocess Engineer, Bioprocess Engineering, Process Science, Boehringer Ingelheim Fremont, Inc.

Norman Packard, PhD, CEO, Daptics

Marcin Paduch, PhD, Senior Staff Scientist, Product Development, GRAIL Inc.

Palani Palaniappan, PhD, Head, Tech Ops & Andover Site, Sarepta Therapeutics

Bernhard Palsson, PhD, Galletti Professor, Bioengineering; Principal Investigator, Systems Biology Research Group, Bioengineering; Professor, Pediatrics, University of California, San Diego

Sofie Pattijn, CTO, ImmunXpert

Marie Østergaard Pedersen, PhD, Specialist, Protein & Peptide Biophysics, Novo Nordisk, Denmark

Dimitrios Peroulis, PhD, Associate Dean for External Affairs, College of Engineering, Purdue University

David Poon, PhD, Executive Director, External R&D and Alliances, Zymeworks, Inc.

Jinshu Qiu, Principal Scientist, Amgen

Christoph Rader, PhD, Associate Professor, Immunology and Microbiology, The Scripps Research Institute
Antibody-Drug Conjugates

G. Jonah Rainey, PhD, CEO, Oriole Biotech, Inc.

Sarav Rajan, PhD, Scientist, Antibody Discovery & Protein Engineering, Medimmune

Alexey Rak, PhD, Head of Bio-Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D

Harun Rashid, PhD, Senior Principal Scientist, Molecular Technology, Ambrx

Sai Reddy, PhD, Associate Professor, Biosystems Science and Engineering, ETH Zurich, Switzerland

Joël Richard, PhD, Vice President, Peptides, CMC & Engineering, Ipsen

Dean Ripple, PhD, Leader, Bioprocess Measurements Group, National Institute of Standards and Technology

Thomas D. Robinson, MD, Managing Director, DNA, Aerosol Therapeutics, LLC

Floyd Romesberg, PhD, Professor, Chemistry, The Scripps Research Institute

Filip Roudnicky, PhD, Senior Scientist, Disease Relevant Cellular Assays, F. Hoffmann-La Roche Ltd.

Sandra E. Rios, PhD, Principal Scientist, Downstream Process Development and Engineering, Merck & Co.

Frank J. Riske, PhD, Senior Consultant, BioProcess Technology Consultants

Christopher J. Roberts, PhD, Professor, Chemical & Biomolecular Engineering,
University of Delaware

Ulrich Rothbauer, PhD, Professor, Natural and Medical Sciences Institute, University of Tübingen, and Co-Founder, ChromoTek GmbH

Jamie Rusconi, PhD, Staff Scientist, Bioanalytical Method Development, Regeneron Pharmaceuticals, Inc.

Gregory A. Sacha, PhD, Senior Research Scientist, Baxter Healthcare Corporation

Darryl Sampey, PhD, President & CEO, Research & Development, BioFactura, Inc.

Stephanie L. Sandefur, MSc, Consultant Biologist, Bioprocess Research & Development, Eli Lilly and Company

Andreas Schaaf, PhD, CSO, Greenovation

Mathias Schaffrath, PhD, Group Head, R&D IDD In vitro Biology & HT Chemistry Library, Chiral & Peptide Purification, Sanofi-Aventis Deutschland GmbH

Peter Schmidt, PhD, Director, Recombinant Technologies Research, CSL Behring

Stefan R. Schmidt, PhD, MBA, Head, Operations (COO), Bioatrium, AG

Jan E. Schnitzer, MD, Director and Professor, Cellular & Molecular Biology, Proteogenomics Research Institute for Systems Medicine (PRISM)

Christian Schöneich, PhD, Takeru Higuchi Distinguished Professor and Chair, Department of Pharmaceutical Chemistry, The University of Kansas

Wim van Schooten, PhD, CSO, TeneoBio, Inc.

Matthew Schwartz, MSc, Senior Scientist, Upstream Process Development, Celgene 

Evgenyi Shalaev, PhD, Executive Director, Pharmaceutical Development, Allergan, Inc.

Beth Sharkey, Scientist I, High Throughput Expression, Adimab, LLC

David Shaw, PhD, Senior Scientist, Cell Culture, Pharma Technical Development, Genentech, Inc.

Wei-Chiang Shen, PhD, John A. Biles Professor, Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy

Yuyi Shen, PhD, Principal Scientist, Technical Department, Grifols, S.A.

Michael Siedler, PhD, Head, NBE High-Throughput and Advanced Formulation Sciences, Development Sciences, AbbVie Deutschland GmbH & Co. KG

Hanno Sjuts, PhD, Postdoctoral Researcher, Protein Crystallization, Pharmaceutical Development Biologics, Sanofi, Germany

Anne Skaja Robinson, PhD, Chair, Chemical and Biomolecular Engineering, Catherine and Henry Boh Professor of Engineering, Tulane Brain Institute Faculty Member, Tulane University

David Smithson, PhD, Scientist, Genentech

Silvino Sousa, MSc, Senior Scientist, Global Protein Sciences, AbbVie Bioresearch Center, AbbVie

Jared Spidel, PhD, Senior Principal Scientist, Antibody Development, Morphotek, Inc

Eva-Maria Strauch, PhD, Assistant Professor, Pharmaceutical and Biomedical Sciences, University of Georgia

Junghae Suh, PhD, Associate Professor, Bioengineering, Rice University

Georgette Suidan, PhD, Scientist II, Alzheimer’s Disease and Dementia Research Unit, Biogen

Challise Sullivan, Life Scientist III, Advanced Solutions Group, Leidos

George Svitel, PhD, Principal Scientist, Merck

Mohammad Tabrizi, PhD, Director, Biologics PPDM, Merck Research Laboratories Palo Alto

Yuichiro Takagi, PhD, Associate Professor, Department of Biochemistry and Molecular Biology, Indiana University School of Medicine

Phanourios Tamamis, PhD, Assistant Professor, Chemical Engineering, Texas A&M University

Rastislav Tamaskovic, PhD, Head, TC Facility, Biochemistry, University of Zurich

Suresh Kumar Thallapuranam, PhD, Professor, Department of Chemistry & Biochemistry, University of Arkansas

Melissa Thomas, PhD, Principal Scientist, Biologics – Protein Technologies, Amgen, Inc.

Mei Tian, PhD, Vice President and Head, External Research, Bioasis Technologies, Inc.

John Timmer PhD, Vice President, Research, INHIBRx

Nicholas Trunfio, PhD, Senior Research Data Scientist, Sartorius Stedim North America, Inc.

Vu Truong, PhD, CSO & CEO, R&D, Aridis Pharmaceuticals Inc.

Danielle Tullman-Ercek, PhD, Associate Professor, Department of Chemical and Biological Engineering, Northwestern University

Mihriban Tuna, DPhil, Vice President, Drug Discovery, F-star Biotechnology, Ltd.

Susumu Uchiyama, PhD, Professor, Department of Biotechnology, Graduate School of Engineering, Osaka University

Mart Ustav, Jr., PhD, Postdoctoral Fellow, Sidhu Lab, University of Toronto

Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark

Moritz von Stosch, PhD, Senior Manager, Technical R&D, GlaxoSmithKline Vaccines

Yulia Vugmeyster, PhD, Associate Director, Clinical Pharmacology, EMD Serono R&D Institute, Inc.

Yogesh Waghmare, PhD, Associate Director, Vector Downstream Process Development, Bluebird Bio

Kerstin Walke, PhD, Head, Pharmaceutical Development Biologicals, Boehringer Ingelheim

Benjamin Walters, PhD, Scientist, Technology, Genentech

Ernst Weber, PhD, Laboratory Head, Biologics Lead Optimization, Project Leader, Ophthalmology, Bayer HealthCare

Brian Webster, PhD, R&D Scientist, Lentigen Technology

Mark Welch, PhD, Vice President, Research and Development, ATUM

Maria Wendt, Head of Science Biologics, Genedata

Krzysztof B. Wicher, PhD, Principal Scientist and Group Leader, Ossianix, Inc.

Ian Wilkinson, PhD, CSO, Research & Development, Absolute Antibody Ltd

John Williams, PhD, Professor, Dept. of Molecular Medicine, Beckman Research Institute; Member, Cancer Immunotherapeutics Program, City of Hope Comprehensive Cancer Center

Andrew Wollacott, PhD, Principal Scientist, Visterra, Inc.

Tuck Seng Wong, PhD, Senior Lecturer, Chemical and Biological Engineering, University of Sheffield

David Wood, PhD, Professor, Chemical & Biomolecular Engineering, The Ohio State University

Liliana Wroblewska, PhD, Principal Scientist, Biomedicine Design, Pfizer

Cong Wu, PhD, Scientist, Biochemical and Cellular Pharmacology, Genentech

George Wu, PhD, Chief Executive Officer, Amberstone

Sam Wu, PhD, Principal Scientist, Janssen BioTherapeutics

Jane (Xiaoyao) Xiao, PhD, Senior Director, Biologics Characterization, Axcel BioPartners

Mingjie Xie, CEO, Rapid Novor Inc 

Alexei Yeliseev, PhD, Staff Scientist, Group Leader, LMBB, NIH, NIAAA

Yihua Bruce Yu, PhD, Professor, Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy

Jingtao Zhang, PhD, Principal Scientist, Pharmaceutical Sciences, Merck Research Laboratories

Jun Zhang, PhD, Senior Scientist, Preformulation, AbbVie 

Qinghai Zhang, PhD, Associate Professor, Integrative Structural and Computational Biology, The Scripps Research Institute

Jie Zhu, PhD, Associate Director, Cell Culture & Fermentation Sciences, MedImmune

Jonathan Zmuda, PhD, Director, Cell Biology, Thermo Fisher Scientific

Sergei Zolotukhin, PhD, Professor, Department of Pediatrics, College of Medicine, University of Florida

Andrew Zydney, PhD, Distinguished Professor, Chemical Engineering, The Pennsylvania State University